Cargando…
Interleukin-34: an important modifier in the pathogenesis of influenza pneumonia
Autores principales: | Xu, Banglao, Lin, Xue, Gong, Yi, Lai, Xiaofei, Ren, Lei, Cao, Ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335987/ https://www.ncbi.nlm.nih.gov/pubmed/34348768 http://dx.doi.org/10.1186/s13054-021-03708-0 |
Ejemplares similares
-
Apoptosis inhibitor of macrophage differentiates bacteria from influenza or COVID-19 in hospitalized adults with community-acquired pneumonia
por: Lai, Xiaofei, et al.
Publicado: (2022) -
Serum Interleukin-34 Levels Are Elevated in Patients with Systemic Lupus Erythematosus
por: Wang, Hongxu, et al.
Publicado: (2016) -
Microbiota-driven interleukin-17 production provides immune protection against invasive candidiasis
por: Li, Mengmeng, et al.
Publicado: (2020) -
IL-27 induces LL-37/CRAMP expression from intestinal epithelial cells: implications for immunotherapy of Clostridioides difficile infection
por: Xu, Banglao, et al.
Publicado: (2021) -
Role of the Mycoplasma pneumoniae/Interleukin-8/Neutrophil Axis in the Pathogenesis of Pneumonia
por: Chen, Zhengrong, et al.
Publicado: (2016)